Cyteir Therapeutics Inc (CYT) is higher by Monday morning, with the stock gaining 1.54% in pre-market trading to 2.64. CYT's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, CYT ranks higher than 73% of stocks. Cyteir Therapeutics Inc has risen 16.59% over the past month, closing at $2.24 on June 5. During this period of time, the stock fell as low as $1.74 and as high as $2.75. CYT has an average analyst recommendation of Buy. The company has an average price target of $2.67.
CYT has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on CYT!